GSK Unveils Two-Year Plan For Consumer Split

GSK preparing to seize “a major opportunity to create a new leader in consumer health” with two-year program which will see the company split in two and create the world's biggest standalone OTC player.

GlaxoSmithKline
• Source: Shutterstock

GlaxoSmithKline PLC has set out concrete plans for creating the world’s largest standalone consumer healthcare company by 2022.

Unveiling a two-year separation program, the UK-based pharma giant's CEO Emma Walmsley said GSK would seize “a major opportunity to...

More from Strategy

DSM-Firmenich Sees Innovation Opportunities For Dietary Supplements

 
• By 

The global ingredients supplier has recently launched microbiome-focused products to expand its supplements offering and has more innovations in the pipeline.

Expanded Distribution In US Helps Drive Up BioGaia Sales

 
• By 

Swedish probiotics player BioGaia is reaping the benefits of increased marketing investments and distribution in the US.

Over The Counter: Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland

 
• By 

HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.

Nestlé Puts VMS Value Brands On Chopping Block To Focus On Premium Market

 
• By 

Nature’s Bounty, Osteo Bi-Flex and Puritan’s Pride are among the dietary supplement brands under strategic review by Nestle as the firm shifts its focus to the premium end of the market.

More from Business

Get To Know: Healthy Aging Specialist Prime Fifty

 
• By 

Established by Max Gowland in 2013, Prime Fifty was founded to address the specific nutritional needs of the over 50s.

DSM-Firmenich Sees Innovation Opportunities For Dietary Supplements

 
• By 

The global ingredients supplier has recently launched microbiome-focused products to expand its supplements offering and has more innovations in the pipeline.

Church & Dwight’s Options For Vitamin Brands: Divest, Find Partner, Shrink Business

 

Divesting C&D’s vitamin business, says CEO Richard Dierker, is “probably the cleanest option” as brands remain a drag on earnings after second quarter.